Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

How strong should you be? new study aims to find out

NCT ID NCT07628530

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will measure leg and handgrip strength in about 2,800 healthy adults and people with chronic lung diseases across Spain, Portugal, and Italy. Researchers want to create normal muscle strength values for these populations and see if the same standards can apply to people with respiratory conditions. Participants attend one visit for strength tests, mobility tasks, and questionnaires.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,815 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Community-dwelling healthy adults and adults with chronic respiratory diseases recruited from participating centres in Spain, Portugal and Italy. Healthy participants will be recruited from the general population to develop reference equations and normative values for isometric quadriceps and handgrip strength. Participants with chronic respiratory diseases will be recruited from clinical settings to externally validate the developed reference equations and assess their clinical applicability.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Healthy adults cohort Inclusion Criteria: * Age between 18-89 years. * Spanish, Portuguese or Italian, or permanently resident in one of those countries for at least five years. * Be community-dwelling (i.e., not hospitalised or institutionalised). * Be functionally independent and capable of performing study assessments without assistance or limiting pain. * Be able to follow verbal instructions in the local language (Spanish, Portuguese or Italian, as appropriate). * Provide written informed consent. Exclusion Criteria: * Acute or chronic musculoskeletal conditions affecting strength: recent fractures, severe osteoarthrosis, ligament injury, acute tendinitis in hands/knee areas, among others. * Recent surgery (e.g., within the past six months) in upper or lower limbs. * Neuromuscular disorders: Parkinson, multiple sclerosis, stroke, peripheral neuropathies, among others. * Non-communicable diseases affecting strength or functional status: active cancer, any unstable heart diseases; any CRD; active rheumatological diseases, obesity (BMI≥30kg/m2), uncontrolled metabolic diseases, among others (not included: controlled dyslipidaemia or arterial hypertension). * Cognitive impairments (e.g., dementia) or psychiatric disorders impairing following instructions. * Aid devices for walking or compromised functional mobility. * Moderate-to-severe pain during the assessment (VAS ≥4). * Systemic corticosteroids use for over one week in the previous six months (i.e., risk of muscle atrophy in type II fibres; or steroid myopathy). * Muscle relaxants use during the previous week (i.e., risk of not full muscle activation). * Pregnancy and postpartum (i.e., potential physiological changes which may alter muscle strength). * Current smoking. Chronic respiratory disease cohort Inclusion criteria: * Aged 18-89 years. * Clinical diagnosis of a chronic respiratory disease (e.g., COPD, interstitial lung disease, asthma, bronchiectasis, cystic fibrosis), confirmed by spirometry or clinical records. * Clinically stable (no exacerbation within the past four weeks). * Capacity to provide informed consent and complete study procedures. Exclusion criteria: * Coexisting conditions which meet the exclusion criteria defined for healthy participants, apart from chronic respiratory diseases. * Current requirement for hospitalisation or acute medical management. * Severe functional limitation preventing completion of assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic respiratory diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Alcalá

    Alcalá de Henares, Madrid, 28805, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.